Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+26.7%
5Y CAGR+49.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+26.7%/yr
Annual compound
5Y CAGR
+49.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
7.5x
Strong expansion
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $63.29M | +1.2% |
| 2024 | $62.54M | +39.6% |
| 2023 | $44.81M | +44.0% |
| 2022 | $31.12M | +26.8% |
| 2021 | $24.55M | +192.5% |
| 2020 | $8.39M | - |